{"id":"https://openalex.org/W2891199463","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps3122","title":"Expansion cohort of partially irradiated tumors on a phase 1 trial of pembrolizumab and ablative radiotherapy.","display_name":"Expansion cohort of partially irradiated tumors on a phase 1 trial of pembrolizumab and ablative radiotherapy.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2891199463","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps3122","mag":"2891199463"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps3122","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps3122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps3122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039382163","display_name":"Sandeep R. Bhave","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep Ramesh BHave","raw_affiliation_strings":["University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason J. Luke","raw_affiliation_strings":["The University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000112064","display_name":"Jeffrey M. Lemons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey M. Lemons","raw_affiliation_strings":["University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071718298","display_name":"Linda A. Janisch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda A. Janisch","raw_affiliation_strings":["University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050168565","display_name":"Robyn D. Hseu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robyn D. Hseu","raw_affiliation_strings":["University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055476105","display_name":"Steven J. Chmura","orcid":"https://orcid.org/0000-0001-8851-7108","observed_orcids":["https://orcid.org/0000-0001-8851-7108"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven J. Chmura","raw_affiliation_strings":["The University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS3122","last_page":"TPS3122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12108","display_name":"Management of metastatic bone disease","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ablative-radiotherapy","display_name":"ablative radiotherapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tumor-control","display_name":"tumor control","score":0.4189999997615814},{"id":"https://openalex.org/keywords/cytoreductive-surgery","display_name":"cytoreductive surgery","score":0.6050000190734863},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6830000281333923},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.593999981880188},{"id":"https://openalex.org/keywords/expansion-cohort","display_name":"expansion cohort","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.922793984413147},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6922343373298645},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6209556460380554},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5305823683738708},{"id":"https://openalex.org/C2781100745","wikidata":"https://www.wikidata.org/wiki/Q1977435","display_name":"Debulking","level":4,"score":0.48209574818611145},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35720813274383545},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.349465548992157},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3161696493625641},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3143501877784729},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.18220952153205872}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps3122","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps3122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps3122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2760326418","https://openalex.org/W2794251304","https://openalex.org/W4376643211","https://openalex.org/W2956359574","https://openalex.org/W3032288818","https://openalex.org/W3169215814","https://openalex.org/W2963460267","https://openalex.org/W3092186599","https://openalex.org/W7214402523","https://openalex.org/W3092159910"],"abstract_inverted_index":{"TPS3122":[0],"Background:":[1],"Preclinical":[2],"studies":[3],"suggest":[4],"multi-organ":[5],"site":[6],"ablative":[7],"radiation":[8,80],"therapy":[9],"(MOSART)":[10],"may":[11],"enhance":[12],"systemic":[13],"anti-tumor":[14],"response":[15],"through":[16,30],"altering":[17],"the":[18,26,43,48,61,68,127,270,284,326,341],"balance":[19],"of":[20,47,50,64,157,181,244],"innate":[21],"and":[22,29,45,167,185,204,216,228,240,330,336],"adaptive":[23],"immunity":[24],"within":[25,283,297],"tumor":[27,32,251,261,313],"microenvironment":[28],"direct":[31],"debulking.":[33],"Previously,":[34],"we":[35,119],"opened":[36,120],"a":[37],"phase":[38],"I":[39],"study":[40],"to":[41,102,124,138,165,265,280,294,310],"evaluate":[42],"safety":[44],"efficacy":[46],"combination":[49],"pembrolizumab":[51],"with":[52,56,78,144,151,340],"MOSART":[53,190,302],"for":[54,202,212,224,237],"patients":[55,66,150],"metastatic":[57,152],"solid":[58],"tumors.":[59],"In":[60,116],"first":[62],"cohort":[63,123],"73":[65],"analyzed,":[67],"combined":[69,143],"therapies":[70],"were":[71],"safe":[72],"in":[73,92,199,209,221],"all":[74,242],"organ":[75],"systems":[76],"studied":[77],"no":[79],"dose":[81],"reductions":[82],"(Luke":[83],"&":[84],"Lemons":[85],"et":[86],"al.":[87],"J":[88],"Clin":[89],"Oncol":[90],"2018,":[91],"press).":[93],"Interestingly,":[94],"large":[95],"partially":[96,131,333],"irradiated":[97,105,132,140,257,334,338],"tumors":[98,106,133,141,335,339],"exhibited":[99],"control":[100,136],"similar":[101,137],"smaller":[103],"completely":[104,139,256,337],"(93%":[107],"vs.":[108],"96%":[109],"at":[110,169,179],"6":[111],"months,":[112],"p":[113],"=":[114],"0.32).":[115],"December":[117],"2017,":[118],"an":[121],"expansion":[122],"formally":[125],"test":[126],"secondary":[128],"hypothesis":[129],"that":[130,254],"exhibit":[134],"local":[135],"when":[142],"immunotherapy.":[145],"Methods:":[146],"We":[147],"are":[148,235,246],"accruing":[149,188],"disease":[153,245],"progressing":[154],"on":[155,194],"standard":[156],"care":[158],"treatment,":[159],"two":[160,233],"or":[161,320],"more":[162],"lesions":[163,234,266],"amenable":[164],"MOSART,":[166],"have":[168],"least":[170,232],"one":[171],"lesion":[172],"greater":[173],"than":[174],"65cc.":[175,259],"Enrollment":[176],"is":[177,186,192,255,258,263,273,293],"currently":[178],"six":[180],"forty":[182],"planned":[183],"subjects,":[184],"actively":[187],"patients.":[189],"dosing":[191],"based":[193],"NRG":[195],"BR-001":[196],"(30":[197],"Gy":[198,208,220],"3":[200,210],"fractions":[201,211,223],"osseous":[203],"spinal":[205],"lesions;":[206,218],"45":[207],"peripheral":[213],"lung,":[214,226],"liver,":[215],"abdominal-pelvic":[217],"50":[219],"5":[222],"central":[225],"mediastinal,":[227],"cervical":[229],"lesions).":[230],"At":[231],"targeted":[236],"each":[238],"patient":[239],"not":[241],"sites":[243],"treated.":[247],"The":[248],"maximum":[249],"gross":[250],"volume":[252,272,277],"(GTV)":[253],"Partial":[260],"irradiation":[262],"administered":[264],">":[267],"65cc":[268],"where":[269],"target":[271],"created":[274],"by":[275,325],"performing":[276],"contraction":[278],"down":[279],"65":[281],"cc":[282],"initial":[285],"radiographically":[286],"defined":[287],"GTV.":[288],"Pembrolizumab":[289],"200mg":[290],"IV":[291],"Q3W":[292],"be":[295,307,323],"initiated":[296],"seven":[298],"days":[299],"after":[300],"final":[301],"treatment.":[303],"RECIST":[304],"1.1":[305],"will":[306,322],"used":[308,309],"assess":[311],"radiated":[312],"progression.":[314],"Control":[315],"(defined":[316],"as":[317],"CR,":[318],"PR,":[319],"SD)":[321],"calculated":[324],"Kaplan":[327],"Meier":[328],"method":[329],"compared":[331],"between":[332],"log-rank":[342],"test.":[343],"Clinical":[344],"trial":[345],"information:":[346],"NCT02608385.":[347]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-09-27T00:00:00"}